APO Research
Talk to an analyst

APO RESEARCH · REPORT

Vasodilators

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Vasodilators Market Analysis and Forecast 2026-2032

21 December 2025198 pages

Choose your research edition.

Industry ResearchVasodilators Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Vasodilators Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Vasodilators Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Vasodilators Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Vasodilators Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Vasodilators market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Vasodilators is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Vasodilators is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Vasodilators is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Vasodilators is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Vasodilators include Teva Pharmaceutical, Sanofi, Jhonson and Johnson, Novartis, Merck, Eli Lilly, Pfizer, GSK and Bayer, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Vasodilators, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Vasodilators, also provides the sales of main regions and countries. Of the upcoming market potential for Vasodilators, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Vasodilators sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Vasodilators market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Vasodilators sales, projected growth trends, production technology, application and end-user industry.

Vasodilators Segment by Company

Teva Pharmaceutical

Sanofi

Jhonson and Johnson

Novartis

Merck

Eli Lilly

Pfizer

GSK

Bayer

Bristol-Myers Squibb

Astra Zeneca

Vasodilators Segment by Type

Venous Dilators

Mixed Dilators

Arterial Dilators

Vasodilators Segment by Application

Heart Failure

Angina

Hypertension

Vasodilators Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Vasodilators market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Vasodilators and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Vasodilators.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Vasodilators in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Vasodilators manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Vasodilators sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Vasodilators Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Venous Dilators Major Manufacturers Table 3. Mixed Dilators Major Manufacturers Table 4. Arterial Dilators Major Manufacturers Table 5. Global Vasodilators Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Heart Failure Major Manufacturers Table 7. Angina Major Manufacturers Table 8. Hypertension Major Manufacturers Table 9. Vasodilators Industry Trends Table 10. Vasodilators Industry Drivers Table 11. Vasodilators Industry Opportunities and Challenges Table 12. Vasodilators Industry Restraints Table 13. Global Vasodilators Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Vasodilators Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Vasodilators Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Vasodilators Revenue Market Share by Region (2021-2026) Table 17. Global Vasodilators Revenue Market Share by Region (2027-2032) Table 18. Global Vasodilators Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k tons) Table 19. Global Vasodilators Sales by Region (2021-2026) & (k tons) Table 20. Global Vasodilators Sales by Region (2027-2032) & (k tons) Table 21. Global Vasodilators Sales Market Share by Region (2021-2026) Table 22. Global Vasodilators Sales Market Share by Region (2027-2032) Table 23. Global Vasodilators Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Vasodilators Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Vasodilators Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Vasodilators Sales Market Share by Manufacturers (2021-2026) Table 27. Global Vasodilators Sales Price (US$/ton) of Manufacturers (2021-2026) Table 28. Global Vasodilators Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Vasodilators Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Vasodilators Manufacturers, Product Type & Application Table 31. Global Vasodilators Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Vasodilators by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Vasodilators Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Vasodilators Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Vasodilators Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Vasodilators Revenue Market Share by Type (2021-2026) Table 38. Global Vasodilators Revenue Market Share by Type (2027-2032) Table 39. Global Vasodilators Sales by Type 2021 VS 2025 VS 2032 (k tons) Table 40. Global Vasodilators Sales by Type (2021-2026) & (k tons) Table 41. Global Vasodilators Sales by Type (2027-2032) & (k tons) Table 42. Global Vasodilators Sales Market Share by Type (2021-2026) Table 43. Global Vasodilators Sales Market Share by Type (2027-2032) Table 44. Global Vasodilators Price by Type (2021-2026) & (US$/ton) Table 45. Global Vasodilators Price by Type (2027-2032) & (US$/ton) Table 46. Global Vasodilators Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Vasodilators Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Vasodilators Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Vasodilators Revenue Market Share by Application (2021-2026) Table 50. Global Vasodilators Revenue Market Share by Application (2027-2032) Table 51. Global Vasodilators Sales by Application 2021 VS 2025 VS 2032 (k tons) Table 52. Global Vasodilators Sales by Application (2021-2026) & (k tons) Table 53. Global Vasodilators Sales by Application (2027-2032) & (k tons) Table 54. Global Vasodilators Sales Market Share by Application (2021-2026) Table 55. Global Vasodilators Sales Market Share by Application (2027-2032) Table 56. Global Vasodilators Price by Application (2021-2026) & (US$/ton) Table 57. Global Vasodilators Price by Application (2027-2032) & (US$/ton) Table 58. Teva Pharmaceutical Company Information Table 59. Teva Pharmaceutical Business Overview Table 60. Teva Pharmaceutical Vasodilators Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 61. Teva Pharmaceutical Vasodilators Product Portfolio Table 62. Teva Pharmaceutical Recent Development Table 63. Sanofi Company Information Table 64. Sanofi Business Overview Table 65. Sanofi Vasodilators Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 66. Sanofi Vasodilators Product Portfolio Table 67. Sanofi Recent Development Table 68. Jhonson and Johnson Company Information Table 69. Jhonson and Johnson Business Overview Table 70. Jhonson and Johnson Vasodilators Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 71. Jhonson and Johnson Vasodilators Product Portfolio Table 72. Jhonson and Johnson Recent Development Table 73. Novartis Company Information Table 74. Novartis Business Overview Table 75. Novartis Vasodilators Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 76. Novartis Vasodilators Product Portfolio Table 77. Novartis Recent Development Table 78. Merck Company Information Table 79. Merck Business Overview Table 80. Merck Vasodilators Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 81. Merck Vasodilators Product Portfolio Table 82. Merck Recent Development Table 83. Eli Lilly Company Information Table 84. Eli Lilly Business Overview Table 85. Eli Lilly Vasodilators Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 86. Eli Lilly Vasodilators Product Portfolio Table 87. Eli Lilly Recent Development Table 88. Pfizer Company Information Table 89. Pfizer Business Overview Table 90. Pfizer Vasodilators Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 91. Pfizer Vasodilators Product Portfolio Table 92. Pfizer Recent Development Table 93. GSK Company Information Table 94. GSK Business Overview Table 95. GSK Vasodilators Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 96. GSK Vasodilators Product Portfolio Table 97. GSK Recent Development Table 98. Bayer Company Information Table 99. Bayer Business Overview Table 100. Bayer Vasodilators Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 101. Bayer Vasodilators Product Portfolio Table 102. Bayer Recent Development Table 103. Bristol-Myers Squibb Company Information Table 104. Bristol-Myers Squibb Business Overview Table 105. Bristol-Myers Squibb Vasodilators Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 106. Bristol-Myers Squibb Vasodilators Product Portfolio Table 107. Bristol-Myers Squibb Recent Development Table 108. Astra Zeneca Company Information Table 109. Astra Zeneca Business Overview Table 110. Astra Zeneca Vasodilators Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 111. Astra Zeneca Vasodilators Product Portfolio Table 112. Astra Zeneca Recent Development Table 113. North America Vasodilators Revenue by Type (2021-2026) & (US$ Million) Table 114. North America Vasodilators Revenue by Type (2027-2032) & (US$ Million) Table 115. North America Vasodilators Sales by Type (2021-2026) & (k tons) Table 116. North America Vasodilators Sales by Type (2027-2032) & (k tons) Table 117. North America Vasodilators Sales Price by Type (2021-2026) & (US$/ton) Table 118. North America Vasodilators Sales Price by Type (2027-2032) & (US$/ton) Table 119. North America Vasodilators Revenue by Application (2021-2026) & (US$ Million) Table 120. North America Vasodilators Revenue by Application (2027-2032) & (US$ Million) Table 121. North America Vasodilators Sales by Application (2021-2026) & (k tons) Table 122. North America Vasodilators Sales by Application (2027-2032) & (k tons) Table 123. North America Vasodilators Sales Price by Application (2021-2026) & (US$/ton) Table 124. North America Vasodilators Sales Price by Application (2027-2032) & (US$/ton) Table 125. North America Vasodilators Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 126. North America Vasodilators Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 127. North America Vasodilators Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 128. North America Vasodilators Sales by Country (2021 VS 2025 VS 2032) & (k tons) Table 129. North America Vasodilators Sales by Country (2021-2026) & (k tons) Table 130. North America Vasodilators Sales by Country (2027-2032) & (k tons) Table 131. North America Vasodilators Sales Price by Country (2021-2026) & (US$/ton) Table 132. North America Vasodilators Sales Price by Country (2027-2032) & (US$/ton) Table 133. United States Vasodilators Revenue (2021-2032) & (US$ Million) Table 134. Canada Vasodilators Revenue (2021-2032) & (US$ Million) Table 135. Mexico Vasodilators Revenue (2021-2032) & (US$ Million) Table 136. Europe Vasodilators Revenue by Type (2021-2026) & (US$ Million) Table 137. Europe Vasodilators Revenue by Type (2027-2032) & (US$ Million) Table 138. Europe Vasodilators Sales by Type (2021-2026) & (k tons) Table 139. Europe Vasodilators Sales by Type (2027-2032) & (k tons) Table 140. Europe Vasodilators Sales Price by Type (2021-2026) & (US$/ton) Table 141. Europe Vasodilators Sales Price by Type (2027-2032) & (US$/ton) Table 142. Europe Vasodilators Revenue by Application (2021-2026) & (US$ Million) Table 143. Europe Vasodilators Revenue by Application (2027-2032) & (US$ Million) Table 144. Europe Vasodilators Sales by Application (2021-2026) & (k tons) Table 145. Europe Vasodilators Sales by Application (2027-2032) & (k tons) Table 146. Europe Vasodilators Sales Price by Application (2021-2026) & (US$/ton) Table 147. Europe Vasodilators Sales Price by Application (2027-2032) & (US$/ton) Table 148. Europe Vasodilators Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 149. Europe Vasodilators Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 150. Europe Vasodilators Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 151. Europe Vasodilators Sales by Country (2021 VS 2025 VS 2032) & (k tons) Table 152. Europe Vasodilators Sales by Country (2021-2026) & (k tons) Table 153. Europe Vasodilators Sales by Country (2027-2032) & (k tons) Table 154. Europe Vasodilators Sales Price by Country (2021-2026) & (US$/ton) Table 155. Europe Vasodilators Sales Price by Country (2027-2032) & (US$/ton) Table 156. Germany Vasodilators Revenue (2021-2032) & (US$ Million) Table 157. France Vasodilators Revenue (2021-2032) & (US$ Million) Table 158. U.K. Vasodilators Revenue (2021-2032) & (US$ Million) Table 159. Italy Vasodilators Revenue (2021-2032) & (US$ Million) Table 160. Russia Vasodilators Revenue (2021-2032) & (US$ Million) Table 161. Spain Vasodilators Revenue (2021-2032) & (US$ Million) Table 162. Netherlands Vasodilators Revenue (2021-2032) & (US$ Million) Table 163. Switzerland Vasodilators Revenue (2021-2032) & (US$ Million) Table 164. Sweden Vasodilators Revenue (2021-2032) & (US$ Million) Table 165. Poland Vasodilators Revenue (2021-2032) & (US$ Million) Table 166. China Vasodilators Revenue by Type (2021-2026) & (US$ Million) Table 167. China Vasodilators Revenue by Type (2027-2032) & (US$ Million) Table 168. China Vasodilators Sales by Type (2021-2026) & (k tons) Table 169. China Vasodilators Sales by Type (2027-2032) & (k tons) Table 170. China Vasodilators Sales Price by Type (2021-2026) & (US$/ton) Table 171. China Vasodilators Sales Price by Type (2027-2032) & (US$/ton) Table 172. China Vasodilators Revenue by Application (2021-2026) & (US$ Million) Table 173. China Vasodilators Revenue by Application (2027-2032) & (US$ Million) Table 174. China Vasodilators Sales by Application (2021-2026) & (k tons) Table 175. China Vasodilators Sales by Application (2027-2032) & (k tons) Table 176. China Vasodilators Sales Price by Application (2021-2026) & (US$/ton) Table 177. China Vasodilators Sales Price by Application (2027-2032) & (US$/ton) Table 178. Asia Vasodilators Revenue by Type (2021-2026) & (US$ Million) Table 179. Asia Vasodilators Revenue by Type (2027-2032) & (US$ Million) Table 180. Asia Vasodilators Sales by Type (2021-2026) & (k tons) Table 181. Asia Vasodilators Sales by Type (2027-2032) & (k tons) Table 182. Asia Vasodilators Sales Price by Type (2021-2026) & (US$/ton) Table 183. Asia Vasodilators Sales Price by Type (2027-2032) & (US$/ton) Table 184. Asia Vasodilators Revenue by Application (2021-2026) & (US$ Million) Table 185. Asia Vasodilators Revenue by Application (2027-2032) & (US$ Million) Table 186. Asia Vasodilators Sales by Application (2021-2026) & (k tons) Table 187. Asia Vasodilators Sales by Application (2027-2032) & (k tons) Table 188. Asia Vasodilators Sales Price by Application (2021-2026) & (US$/ton) Table 189. Asia Vasodilators Sales Price by Application (2027-2032) & (US$/ton) Table 190. Asia Vasodilators Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 191. Asia Vasodilators Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 192. Asia Vasodilators Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 193. Asia Vasodilators Sales by Country (2021 VS 2025 VS 2032) & (k tons) Table 194. Asia Vasodilators Sales by Country (2021-2026) & (k tons) Table 195. Asia Vasodilators Sales by Country (2027-2032) & (k tons) Table 196. Asia Vasodilators Sales Price by Country (2021-2026) & (US$/ton) Table 197. Asia Vasodilators Sales Price by Country (2027-2032) & (US$/ton) Table 198. Japan Vasodilators Revenue (2021-2032) & (US$ Million) Table 199. South Korea Vasodilators Revenue (2021-2032) & (US$ Million) Table 200. India Vasodilators Revenue (2021-2032) & (US$ Million) Table 201. Australia Vasodilators Revenue (2021-2032) & (US$ Million) Table 202. Taiwan Vasodilators Revenue (2021-2032) & (US$ Million) Table 203. Southeast Asia Vasodilators Revenue (2021-2032) & (US$ Million) Table 204. SAMEA Vasodilators Revenue by Type (2021-2026) & (US$ Million) Table 205. SAMEA Vasodilators Revenue by Type (2027-2032) & (US$ Million) Table 206. SAMEA Vasodilators Sales by Type (2021-2026) & (k tons) Table 207. SAMEA Vasodilators Sales by Type (2027-2032) & (k tons) Table 208. SAMEA Vasodilators Sales Price by Type (2021-2026) & (US$/ton) Table 209. SAMEA Vasodilators Sales Price by Type (2027-2032) & (US$/ton) Table 210. SAMEA Vasodilators Revenue by Application (2021-2026) & (US$ Million) Table 211. SAMEA Vasodilators Revenue by Application (2027-2032) & (US$ Million) Table 212. SAMEA Vasodilators Sales by Application (2021-2026) & (k tons) Table 213. SAMEA Vasodilators Sales by Application (2027-2032) & (k tons) Table 214. SAMEA Vasodilators Sales Price by Application (2021-2026) & (US$/ton) Table 215. SAMEA Vasodilators Sales Price by Application (2027-2032) & (US$/ton) Table 216. SAMEA Vasodilators Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 217. SAMEA Vasodilators Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 218. SAMEA Vasodilators Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 219. SAMEA Vasodilators Sales by Country (2021 VS 2025 VS 2032) & (k tons) Table 220. SAMEA Vasodilators Sales by Country (2021-2026) & (k tons) Table 221. SAMEA Vasodilators Sales by Country (2027-2032) & (k tons) Table 222. SAMEA Vasodilators Sales Price by Country (2021-2026) & (US$/ton) Table 223. SAMEA Vasodilators Sales Price by Country (2027-2032) & (US$/ton) Table 224. Brazil Vasodilators Revenue (2021-2032) & (US$ Million) Table 225. Argentina Vasodilators Revenue (2021-2032) & (US$ Million) Table 226. Chile Vasodilators Revenue (2021-2032) & (US$ Million) Table 227. Colombia Vasodilators Revenue (2021-2032) & (US$ Million) Table 228. Peru Vasodilators Revenue (2021-2032) & (US$ Million) Table 229. Saudi Arabia Vasodilators Revenue (2021-2032) & (US$ Million) Table 230. Israel Vasodilators Revenue (2021-2032) & (US$ Million) Table 231. UAE Vasodilators Revenue (2021-2032) & (US$ Million) Table 232. Turkey Vasodilators Revenue (2021-2032) & (US$ Million) Table 233. Iran Vasodilators Revenue (2021-2032) & (US$ Million) Table 234. Egypt Vasodilators Revenue (2021-2032) & (US$ Million) Table 235. Key Raw Materials Table 236. Raw Materials Key Suppliers Table 237. Vasodilators Distributors List Table 238. Vasodilators Customers List Table 239. Research Programs/Design for This Report Table 240. Authors List of This Report Table 241. Secondary Sources Table 242. Primary Sources List of Figures Figure 1. Vasodilators Image Figure 2. Global Vasodilators Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Vasodilators Market Size Share 2021 VS 2025 VS 2032 Figure 4. Venous Dilators Image Figure 5. Mixed Dilators Image Figure 6. Arterial Dilators Image Figure 7. Global Vasodilators Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Vasodilators Market Size Share 2021 VS 2025 VS 2032 Figure 9. Heart Failure Image Figure 10. Angina Image Figure 11. Hypertension Image Figure 12. Global Vasodilators Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Vasodilators Revenue (2021-2032) & (US$ Million) Figure 14. Global Vasodilators Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Vasodilators Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Vasodilators Revenue Market Share by Region (2021-2032) Figure 17. Global Vasodilators Sales (2021-2032) & (k tons) Figure 18. Global Vasodilators Sales by Region: 2021 VS 2025 VS 2032 (k tons) Figure 19. Global Vasodilators Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Vasodilators Sales YoY (2021-2032) & (k tons) Figure 21. Europe Vasodilators Sales YoY (2021-2032) & (k tons) Figure 22. China Vasodilators Sales YoY (2021-2032) & (k tons) Figure 23. Asia (Excluding China) Vasodilators Sales YoY (2021-2032) & (k tons) Figure 24. South America, Middle East and Africa Vasodilators Sales YoY (2021-2032) & (k tons) Figure 25. Global Vasodilators Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Vasodilators Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Vasodilators Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Vasodilators Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Vasodilators Revenue Market Share by Type (2021-2032) Figure 31. Global Vasodilators Sales by Type (2021 VS 2025 VS 2032) & (k tons) Figure 32. Global Vasodilators Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Vasodilators Sales Market Share by Type (2021-2032) Figure 34. Global Vasodilators Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Vasodilators Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Vasodilators Revenue Market Share by Application (2021-2032) Figure 37. Global Vasodilators Sales by Application (2021 VS 2025 VS 2032) & (k tons) Figure 38. Global Vasodilators Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Vasodilators Sales Market Share by Application (2021-2032) Figure 40. North America Vasodilators Revenue Share by Type (2021-2032) Figure 41. North America Vasodilators Sales Share by Type (2021-2032) Figure 42. North America Vasodilators Revenue Share by Application (2021-2032) Figure 43. North America Vasodilators Sales Share by Application (2021-2032) Figure 44. North America Vasodilators Revenue Share by Country (2021-2032) Figure 45. North America Vasodilators Sales Share by Country (2021-2032) Figure 46. Europe Vasodilators Revenue Share by Type (2021-2032) Figure 47. Europe Vasodilators Sales Share by Type (2021-2032) Figure 48. Europe Vasodilators Revenue Share by Application (2021-2032) Figure 49. Europe Vasodilators Sales Share by Application (2021-2032) Figure 50. Europe Vasodilators Revenue Share by Country (2021-2032) Figure 51. Europe Vasodilators Sales Share by Country (2021-2032) Figure 52. China Vasodilators Revenue Share by Type (2021-2032) Figure 53. China Vasodilators Sales Share by Type (2021-2032) Figure 54. China Vasodilators Revenue Share by Application (2021-2032) Figure 55. China Vasodilators Sales Share by Application (2021-2032) Figure 56. Asia Vasodilators Revenue Share by Type (2021-2032) Figure 57. Asia Vasodilators Sales Share by Type (2021-2032) Figure 58. Asia Vasodilators Revenue Share by Application (2021-2032) Figure 59. Asia Vasodilators Sales Share by Application (2021-2032) Figure 60. Asia Vasodilators Revenue Share by Country (2021-2032) Figure 61. Asia Vasodilators Sales Share by Country (2021-2032) Figure 62. SAMEA Vasodilators Revenue Share by Type (2021-2032) Figure 63. SAMEA Vasodilators Sales Share by Type (2021-2032) Figure 64. SAMEA Vasodilators Revenue Share by Application (2021-2032) Figure 65. SAMEA Vasodilators Sales Share by Application (2021-2032) Figure 66. SAMEA Vasodilators Revenue Share by Country (2021-2032) Figure 67. SAMEA Vasodilators Sales Share by Country (2021-2032) Figure 68. Vasodilators Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Vasodilators Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Venous Dilators
  • Mixed Dilators
  • Arterial Dilators
Applications
  • Heart Failure
  • Angina
  • Hypertension
Companies covered
  • Teva Pharmaceutical
  • Sanofi
  • Jhonson and Johnson
  • Novartis
  • Merck
  • Eli Lilly
  • Pfizer
  • GSK
  • Bayer
  • Bristol-Myers Squibb
  • Astra Zeneca

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Vasodilators Market by Type
  3. 1.2.1 Global Vasodilators Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Venous Dilators
  5. 1.2.3 Mixed Dilators
  6. 1.2.4 Arterial Dilators
  7. 1.3 Vasodilators Market by Application
  8. 1.3.1 Global Vasodilators Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Heart Failure
  10. 1.3.3 Angina
  11. 1.3.4 Hypertension
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Vasodilators Market Dynamics
  1. 2.1 Vasodilators Industry Trends
  2. 2.2 Vasodilators Industry Drivers
  3. 2.3 Vasodilators Industry Opportunities and Challenges
  4. 2.4 Vasodilators Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Vasodilators Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Vasodilators Revenue by Region
  3. 3.2.1 Global Vasodilators Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Vasodilators Revenue by Region (2021-2026)
  5. 3.2.3 Global Vasodilators Revenue by Region (2027-2032)
  6. 3.2.4 Global Vasodilators Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Vasodilators Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Vasodilators Sales by Region
  9. 3.4.1 Global Vasodilators Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Vasodilators Sales by Region (2021-2026)
  11. 3.4.3 Global Vasodilators Sales by Region (2027-2032)
  12. 3.4.4 Global Vasodilators Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Vasodilators Revenue by Manufacturers
  2. 4.1.1 Global Vasodilators Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Vasodilators Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Vasodilators Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Vasodilators Sales by Manufacturers
  6. 4.2.1 Global Vasodilators Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Vasodilators Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Vasodilators Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Vasodilators Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Vasodilators Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Vasodilators Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Vasodilators Manufacturers, Product Type & Application
  13. 4.7 Global Vasodilators Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Vasodilators Market CR5 and HHI
  16. 4.8.2 2025 Vasodilators Tier 1, Tier 2, and Tier 3
5 Vasodilators Market by Type
  1. 5.1 Global Vasodilators Revenue by Type
  2. 5.1.1 Global Vasodilators Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Vasodilators Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Vasodilators Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Vasodilators Sales by Type
  6. 5.2.1 Global Vasodilators Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Vasodilators Sales by Type (2021-2032) & (k tons)
  8. 5.2.3 Global Vasodilators Sales Market Share by Type (2021-2032)
  9. 5.3 Global Vasodilators Price by Type
6 Vasodilators Market by Application
  1. 6.1 Global Vasodilators Revenue by Application
  2. 6.1.1 Global Vasodilators Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Vasodilators Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Vasodilators Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Vasodilators Sales by Application
  6. 6.2.1 Global Vasodilators Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Vasodilators Sales by Application (2021-2032) & (k tons)
  8. 6.2.3 Global Vasodilators Sales Market Share by Application (2021-2032)
  9. 6.3 Global Vasodilators Price by Application
7 Company Profiles
  1. 7.1 Teva Pharmaceutical
  2. 7.1.1 Teva Pharmaceutical Company Information
  3. 7.1.2 Teva Pharmaceutical Business Overview
  4. 7.1.3 Teva Pharmaceutical Vasodilators Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Teva Pharmaceutical Vasodilators Product Portfolio
  6. 7.1.5 Teva Pharmaceutical Recent Developments
  7. 7.2 Sanofi
  8. 7.2.1 Sanofi Company Information
  9. 7.2.2 Sanofi Business Overview
  10. 7.2.3 Sanofi Vasodilators Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Sanofi Vasodilators Product Portfolio
  12. 7.2.5 Sanofi Recent Developments
  13. 7.3 Jhonson and Johnson
  14. 7.3.1 Jhonson and Johnson Company Information
  15. 7.3.2 Jhonson and Johnson Business Overview
  16. 7.3.3 Jhonson and Johnson Vasodilators Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Jhonson and Johnson Vasodilators Product Portfolio
  18. 7.3.5 Jhonson and Johnson Recent Developments
  19. 7.4 Novartis
  20. 7.4.1 Novartis Company Information
  21. 7.4.2 Novartis Business Overview
  22. 7.4.3 Novartis Vasodilators Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Novartis Vasodilators Product Portfolio
  24. 7.4.5 Novartis Recent Developments
  25. 7.5 Merck
  26. 7.5.1 Merck Company Information
  27. 7.5.2 Merck Business Overview
  28. 7.5.3 Merck Vasodilators Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Merck Vasodilators Product Portfolio
  30. 7.5.5 Merck Recent Developments
  31. 7.6 Eli Lilly
  32. 7.6.1 Eli Lilly Company Information
  33. 7.6.2 Eli Lilly Business Overview
  34. 7.6.3 Eli Lilly Vasodilators Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Eli Lilly Vasodilators Product Portfolio
  36. 7.6.5 Eli Lilly Recent Developments
  37. 7.7 Pfizer
  38. 7.7.1 Pfizer Company Information
  39. 7.7.2 Pfizer Business Overview
  40. 7.7.3 Pfizer Vasodilators Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Pfizer Vasodilators Product Portfolio
  42. 7.7.5 Pfizer Recent Developments
  43. 7.8 GSK
  44. 7.8.1 GSK Company Information
  45. 7.8.2 GSK Business Overview
  46. 7.8.3 GSK Vasodilators Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 GSK Vasodilators Product Portfolio
  48. 7.8.5 GSK Recent Developments
  49. 7.9 Bayer
  50. 7.9.1 Bayer Company Information
  51. 7.9.2 Bayer Business Overview
  52. 7.9.3 Bayer Vasodilators Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Bayer Vasodilators Product Portfolio
  54. 7.9.5 Bayer Recent Developments
  55. 7.10 Bristol-Myers Squibb
  56. 7.10.1 Bristol-Myers Squibb Company Information
  57. 7.10.2 Bristol-Myers Squibb Business Overview
  58. 7.10.3 Bristol-Myers Squibb Vasodilators Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Bristol-Myers Squibb Vasodilators Product Portfolio
  60. 7.10.5 Bristol-Myers Squibb Recent Developments
  61. 7.11 Astra Zeneca
  62. 7.11.1 Astra Zeneca Company Information
  63. 7.11.2 Astra Zeneca Business Overview
  64. 7.11.3 Astra Zeneca Vasodilators Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Astra Zeneca Vasodilators Product Portfolio
  66. 7.11.5 Astra Zeneca Recent Developments
8 North America
  1. 8.1 North America Vasodilators Market Size by Type
  2. 8.1.1 North America Vasodilators Revenue by Type (2021-2032)
  3. 8.1.2 North America Vasodilators Sales by Type (2021-2032)
  4. 8.1.3 North America Vasodilators Price by Type (2021-2032)
  5. 8.2 North America Vasodilators Market Size by Application
  6. 8.2.1 North America Vasodilators Revenue by Application (2021-2032)
  7. 8.2.2 North America Vasodilators Sales by Application (2021-2032)
  8. 8.2.3 North America Vasodilators Price by Application (2021-2032)
  9. 8.3 North America Vasodilators Market Size by Country
  10. 8.3.1 North America Vasodilators Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Vasodilators Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Vasodilators Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Vasodilators Market Size by Type
  2. 9.1.1 Europe Vasodilators Revenue by Type (2021-2032)
  3. 9.1.2 Europe Vasodilators Sales by Type (2021-2032)
  4. 9.1.3 Europe Vasodilators Price by Type (2021-2032)
  5. 9.2 Europe Vasodilators Market Size by Application
  6. 9.2.1 Europe Vasodilators Revenue by Application (2021-2032)
  7. 9.2.2 Europe Vasodilators Sales by Application (2021-2032)
  8. 9.2.3 Europe Vasodilators Price by Application (2021-2032)
  9. 9.3 Europe Vasodilators Market Size by Country
  10. 9.3.1 Europe Vasodilators Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Vasodilators Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Vasodilators Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Vasodilators Market Size by Type
  2. 10.1.1 China Vasodilators Revenue by Type (2021-2032)
  3. 10.1.2 China Vasodilators Sales by Type (2021-2032)
  4. 10.1.3 China Vasodilators Price by Type (2021-2032)
  5. 10.2 China Vasodilators Market Size by Application
  6. 10.2.1 China Vasodilators Revenue by Application (2021-2032)
  7. 10.2.2 China Vasodilators Sales by Application (2021-2032)
  8. 10.2.3 China Vasodilators Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Vasodilators Market Size by Type
  2. 11.1.1 Asia Vasodilators Revenue by Type (2021-2032)
  3. 11.1.2 Asia Vasodilators Sales by Type (2021-2032)
  4. 11.1.3 Asia Vasodilators Price by Type (2021-2032)
  5. 11.2 Asia Vasodilators Market Size by Application
  6. 11.2.1 Asia Vasodilators Revenue by Application (2021-2032)
  7. 11.2.2 Asia Vasodilators Sales by Application (2021-2032)
  8. 11.2.3 Asia Vasodilators Price by Application (2021-2032)
  9. 11.3 Asia Vasodilators Market Size by Country
  10. 11.3.1 Asia Vasodilators Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Vasodilators Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Vasodilators Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Vasodilators Market Size by Type
  2. 12.1.1 SAMEA Vasodilators Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Vasodilators Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Vasodilators Price by Type (2021-2032)
  5. 12.2 SAMEA Vasodilators Market Size by Application
  6. 12.2.1 SAMEA Vasodilators Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Vasodilators Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Vasodilators Price by Application (2021-2032)
  9. 12.3 SAMEA Vasodilators Market Size by Country
  10. 12.3.1 SAMEA Vasodilators Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Vasodilators Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Vasodilators Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Vasodilators Value Chain Analysis
  2. 13.1.1 Vasodilators Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Vasodilators Production Mode & Process
  6. 13.2 Vasodilators Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Vasodilators Distributors
  9. 13.2.3 Vasodilators Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst